Literature DB >> 8871614

Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice.

K Takeda1, M Kamanaka, T Tanaka, T Kishimoto, S Akira.   

Abstract

IL-13 shares many biologic responses with IL-4. In contrast to well-characterized IL-4 signaling pathways, which utilize STAT6 and 4PS/IRS2, IL-13 signaling pathways are poorly understood. Recent studies performed with STAT6-deficient mice have demonstrated that STAT6 plays an essential role in IL-4 signaling. In this study, the functions of peritoneal macrophages of STAT6-deficient mice in response to IL-13 were analyzed. In STAT6-deficient mice, neither morphologic changes nor augmentation of MHC class II expression in response to IL-13 was observed. In addition, IL-13 did not decrease the nitric oxide production by activated macrophages. Taken together, these results suggest that the macrophage functions in response to IL-13 were impaired in STAT6-deficient mice, indicating that IL-13 and IL-4 share the signaling pathway via STAT6.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871614

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

Review 1.  Jaks, STATs, Cytokines, and Sepsis.

Authors:  Melanie J Scott; Christopher J Godshall; William G Cheadle
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

Review 2.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

3.  Differential IL-4/Stat6 activities correlate with differential expression of regulatory genes SOCS-1, SHP-1, and PP2A in colon cancer cells.

Authors:  Qin Yuan; Pin Dong Li; Ben Hui Li; Xian Zi Yang; Shuang Bing Xu; Xiao Hong Liu; Fu Xiang Zhou; Wen Jie Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2008-06-07       Impact factor: 4.553

4.  IL-13 R130Q, a common variant associated with allergy and asthma, enhances effector mechanisms essential for human allergic inflammation.

Authors:  Frank D Vladich; Susan M Brazille; Debra Stern; Michael L Peck; Raffaella Ghittoni; Donata Vercelli
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

5.  Histamine affects STAT6 phosphorylation via its effects on IL-4 secretion: role of H1 receptors in the regulation of IL-4 production.

Authors:  Geetanjali Kharmate; Zhongfeng Liu; Eric Patterson; Manzoor M Khan
Journal:  Int Immunopharmacol       Date:  2006-11-20       Impact factor: 4.932

6.  Dysregulation of janus kinases and signal transducers and activators of transcription in cancer.

Authors:  Ana P Costa-Pereira; Nair A Bonito; Michael J Seckl
Journal:  Am J Cancer Res       Date:  2011-06-22       Impact factor: 6.166

Review 7.  Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency.

Authors:  J J O'Shea; L D Notarangelo; J A Johnston; F Candotti
Journal:  J Clin Immunol       Date:  1997-11       Impact factor: 8.317

8.  HIF1A up-regulates the ADORA2B receptor on alternatively activated macrophages and contributes to pulmonary fibrosis.

Authors:  Kemly Philip; Tingting Weng Mills; Jonathan Davies; Ning-Yuan Chen; Harry Karmouty-Quintana; Fayong Luo; Jose G Molina; Javier Amione-Guerra; Neeraj Sinha; Ashrith Guha; Holger K Eltzschig; Michael R Blackburn
Journal:  FASEB J       Date:  2017-07-12       Impact factor: 5.191

9.  The Interleukin-13 Receptor-α1 Chain Is Essential for Induction of the Alternative Macrophage Activation Pathway by IL-13 but Not IL-4.

Authors:  Faruk Sheikh; Harold Dickensheets; Joao Pedras-Vasconcelos; Thirumalai Ramalingam; Laura Helming; Siamon Gordon; Raymond P Donnelly
Journal:  J Innate Immun       Date:  2015-03-07       Impact factor: 7.349

10.  Signal transducer and activator of transcription 6 polymorphism and asthma risk: a meta-analysis.

Authors:  Bin Li; Wei Nie; Qiong Li; Hongchao Liu; Shiyuan Liu
Journal:  Int J Clin Exp Med       Date:  2013-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.